CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus
- Published on 02/09/2024
- Reading time: 4 min.
Jule Taubmann , Fabian Müller , Melek Yalcin Mutlu , Simon Völkl , Michael Aigner , Aline Bozec , Andreas Mackensen , Ricardo Grieshaber‐Bouyer , Georg Schett
Friedrich‐Alexander‐Universität Erlangen Nürnberg and Universitätsklinikum Erlangen Erlangen Germany
Abstract
B cell generation of autoantibodies is a crucial step in the pathogenesis of systemic lupus erythematosus (SLE). After their differentiation in the bone marrow, B cells populate the secondary lymphatic organs, where they undergo further maturation leading to the development of memory B cells as well as antibody‐producing plasmablasts and plasma cells. Targeting B cells is an important strategy to treat autoimmune diseases such as SLE, in which B cell tolerance is disturbed...
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Rheumatology
Receive our newsletter to stay up to date with the latest news in Rheumatology